How do GLP-1 drugs reshape healthcare economics, the Social Security and Medicare timeline, and the food industry
What Happens When a Drug Rewires Your Brain's Reward System — and the Rest of the Economy Has to Catch Up?
How will widespread GLP-1 adoption reshape labor force participation, disability insurance (SSDI), military readiness, and long-term care insurance — second-order effects beyond healthcare costs
What Happens to Jobs, Disability Checks, the Army, and Insurance When Millions of People Take Ozempic?
How will the convergence of AI, biotech, and longevity science reshape healthcare economics and life insurance
What Happens When We Start Living Much Longer — and Who Pays for It?
What are the economics and ethics of longevity science — is extending healthy lifespan a real industry or a billionaire fantasy
Can We Actually Live Longer, and Who Gets To?
How is the US healthcare system structured, why does it cost twice as much as peers, and what would it take to fix
Why Does American Healthcare Cost So Much, and What Would Actually Fix It?
How will AI transform drug discovery, clinical trials, and diagnostics — and which companies are leading
How Is AI Changing the Way We Make Medicines and Catch Diseases?
What happens to healthcare systems worldwide as populations age — who's adapting and who's heading for crisis
What Happens When a Society Gets Old Faster Than It Can Afford?
How will GLP-1 drugs (Ozempic, Mounjaro) reshape healthcare economics, food industry, and insurance
What Happens to Money, Food, and Insurance When Millions of People Take Ozempic?
What is the real state of gene therapy and CRISPR — which diseases are actually treatable, and at what cost
Gene Therapy and CRISPR: What's Actually Working, What's Broken, and Why It Costs So Much
What is private equity doing to the real economy — healthcare, housing, retail — and what are the systemic risks
When Investors Buy the Places We Live and Work: What a Knowledge Graph Reveals